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EXTL3-interacting endometriosis-
specific serum factors induce colony 
formation of endometrial stromal 
cells
Alar Aints1,2, Signe Mölder3 & Andres Salumets1,3,4,5
Endometriosis is a benign chronic condition characterized by the existence of endometrial-like stroma 
and glandular tissue in extrauterine locations. The molecular mechanisms of its pathogenesis have not 
been elucidated. We have studied the role of EXTL3 (exostosin-like 3) in endometriosis and found that 
it is expressed in endometrial tissue as well as endometriosis lesions. We have found that serum from 
endometriosis patients contains a factor or factors, which interact with EXTL3 resulting in strongly 
increased colony formation in regenerating cell culture. We also found increased anti-EXTL3 antibodies 
in endometriosis patients’ sera. EXTL3 is an N-acetyl glucosamine (GlcNAc) transferase, performing a 
key step in heparan sulfate (HS) glucosaminoglycan synthesis. Many viruses replicate in regenerating 
epithelial cells and use HS as a receptor for cell entry. We measured antibody titres to viruses, which 
use HS as a receptor for cell entry, and found rarely increased titres for these viruses in endometriosis 
sera, whereas titres to viruses using other receptors were equally distributed in study groups. The data 
indicate that perturbation of HS metabolism is associated with endometriosis.
Endometriosis is defined as the existence of endometrial-like stromal and glandular tissue in extrauterine loca-
tions, most often on the peritoneum in the abdominal cavity, or in the ovaries. It is responsive to cyclic hormonal 
changes, thereby undergoing bleeding and regeneration, resulting in significant discomfort. It is a very common 
disease occurring in 6 to 10% of women1,2. Different sources report a slightly different association with symptoms. 
In women with pain, or infertility, the occurrence is 35–50%3. About 25 to 50% of infertile women have endome-
triosis, and conversely, 30 to 50% of women with endometriosis are infertile4.
Specific molecular mechanisms resulting in ectopic formation of endometrial tissue have not been identified. 
Serum factors have been found to induce umbilical cord stromal cell differentiation into endometrial epithelial 
cells, however, the nature of these factors, nor their target molecule has not been identified5. Autoimmunity has 
also been associated with endometriosis. Endometrial epithelium has been described as highly immunogenic, 
and antibody levels to endometrial surface antigens have been found to correlate to endometriosis stage6. To 
investigate endometriosis-associated autoantibodies, we have previously used phage display 7 amino acid library 
panning using immunoglobulin G (IgG) antibodies purified from endometriosis patients’ sera. This method iden-
tified, among others, a peptide with homology to EXTL37.
EXT proteins function as N-acetyl glucosamine (GlcNAc) transferases involved in synthesis of glycosamino-
glycan (GAG), specifically heparan sulfate (HS). HS synthesis proceeds initially by transfer of xylose (Xyl) to a 
specific serine residue in the protein. This takes place in the endoplasmatic reticulum. Further modification by 
two galactose (Gal) units and a glucuronic acid (GlcA) is completed in the Golgi apparatus to yield the common 
linker tetrasaccharide βGlcA-1,3-βGal-1,3-βGal-1,4-βXyl-(Serine). Then, HS and heparin synthesis is continued 
by adding a GlcNAc residue by exostosin family transferases, like EXTL38.
We hypothesized, that since many viruses infect epithelial stem cells, they may be related to the pathogenesis 
of endometriosis. DNA viruses have been studied in this context, and contradictory results have been found9–11. 
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Interestingly, HS is a cell entry receptor for many viruses, such as papilloma- and herpesviruses. Binding to and 
entry into cells for these viruses requires intact and correctly sulfated HS12. Since EXT proteins are involved in the 
synthesis of these viral entry receptors, we decided to compare the distribution of antibody titers to viruses, which 
use HS as a receptor vs. titers to viruses using different receptors.
EXTL3 also functions as a signaling receptor. In keratinocytes, it has been found to inhibit terminal differen-
tiation and increase cell proliferation via activation of phosphatidylinositol 3 kinase (PI3K) and the kinase AKT. 
EXTL3 signaling is increased in psoriasis, where it is mediated by overexpression of regenerating islet-derived 
protein 3a (REG3A), a cognate ligand for EXTL3, as well as an antimicrobial lectin13. Mutations in EXT family 
genes are associated with multiple exostoses syndrome, characterized by excessive growth of bone tissue resulting 
in osteochondroma formation and deformities. Therefore, EXTL3 was chosen as a plausible study candidate for a 
target molecule in endometriosis; a disorder involving excessive cellular proliferation.
Materials and Methods
Patients. All patients signed an informed consent form before the donation of serum and biopsies, approved 
by the Research Ethics Committee of the University of Tartu (219/M-15). All methods were performed in accord-
ance with the relevant guidelines and regulations. All patients were studied laparoscopically in Tartu University 
Hospital and endometriosis was confirmed or excluded. Removed endometriosis foci were kept on ice in sterile 
cell culture medium and processed the same day. The samples from healthy controls were collected during routine 
ambulatory visits. The healthy controls were not laparoscopically studied (because they had no complaints), while 
infertile patients were laparoscopically proven to be endometriosis-free. For statistical analysis the healthy and 
infertile groups were pooled and labelled as endometriosis-free (N). There was no difference between the healthy 
and infertile subgroups regarding the studied parameters. The first ELISA study, focused on viral titers, involved 
9 endometriosis patients, 8 endometriosis-free infertile patients and 8 healthy controls. The endometriosis group 
included 7 stage I-II patients and two stage III patients. Four were also diagnosed with infertility. The second 
ELISA study, focused on autoantigenic targets, involved 15 endometriosis patients, 15 endometriosis-free infertile 
patients and 14 healthy controls. The endometriosis group included two stage I-II patients and 13 stage III-IV 
patients. The sera were collected using BD Vacutainer Clot Activating Tubes (Ref#367896), sera were aliquoted 
after clotting and stored at −80 °C until use. Endometrial biopsies were collected using Pipelle de Cornier Mark 
II, Laboratoire CCD, Paris, France, Ref#111020100.
PCR. RNA was extracted from endometrioma capsule material with Qiagen RNA extraction kit (Qiagen, 
Germany) and reverse transcribed using Sigma AMV Reverse transcriptase (Sigma-Aldrich, USA). Functional 
EXTL3 mRNA expression was detected with primers EXTL3 5′2510: CCTCACCCAGATACCTCCGCAA and 
EXTL3 3′3022: CTCTCCACACCCGGAACCCAAA. Full-length cDNA was cloned with primers EXTL3 5′734 
CCCCTCGAGACCATGACAGGCTATACCATGCTGC and EXTL3 3′3505 CCCGGTACCCAAGATGAACT 
TGAAGC. The forward primer contained a consensus translation initiation sequence element (ACC, bold) and 
reverse primer contained mutated stop codon (bold). The truncated EXTL3-ΔC construct was prepared with 
primer EXTL3 3′1971-S CGTGCTGGTACCGGGAACATTGCCTCCAAGC. The PCR products were cleaved 
with XhoI and KpnI restriction enzymes (sites underlined), ligated into pEGFP-N3 vector (Clontech, USA) and 
verified by sequencing.
Cells. Primary eutopic endometrial stromal cells (ESC) were prepared from biopsies using collagenase 
(Sigma-Aldrich, USA) digestion for 1 hour at 37 °C. The cell suspensions were filtered through 50 µm and 35 µm 
strainer (Cell Strainer Cap, BD Falcon, USA) to separate cells from undigested tissue fragments. The cells were 
plated in DMEM/F12 medium with 10% (v/v) FBS, penicillin, streptomycin and amphotericin B and passaged 
twice to remove epithelial cells.
For the experiments, endometrial stromal cells from endometriosis-free patients E343 and E305 (primary 
cells ESC-343 and ESC-305) were plated on 6-well plates (Greiner Bio One International GmbH, Germany) and 
transfected the following day using FuGENE 6 transfection reagent (Promega Corporation, Madison, WI, USA) 
and 2 µg plasmid DNA per well. Human serum (10% v/v) and estradiol (10 µM) was added 4 hours after transfec-
tion. The cells were photographed 24 h after transfection, returned to the incubator and left unattended until col-
onies formed. Live cell imaging was done on a Nikon Eclipse TS100 inverted microscope equipped with Digital 
Sight imaging system.
Immunostaining. The cells were washed in PBS, and fixed in 10% (w/v) formaldehyde for 15 min at room 
temperature. The cells were washed again, and blocked in 2% (w/v) human albumin in PBS overnight at 4 °C. 
Antibodies were added in blocking solution for 4 hours at room temperature. Anti-SUSD2-phycoerythrin con-
jugate, clone W5C5 was purchased from BioLegend, San Diego, California, USA, Cat#327406 Lot#B167847, 
and anti CD9-FITC conjugate was purchased from Novus Biologicals, Cambridge, UK, Cat#NB110-81617, 
Lot#520464. DAPI (D9542, Sigma-Aldrich) was used to stain nuclei. Microphotos were taken using Cytation 5 
cell imaging multi-mode reader from BioTek, Winooski, VT, USA.
ELISA. Peptides (Table 1) were synthesized and biotin-conjugated to 96-well ELISA plates at Jena Peptide 
Technologies GmbH (Jena, Germany). All wells were in duplicate. The plates were blocked in PBS-Tween-20 
(0.1% v/v)-Human Albumin (0.05% w/v) overnight, incubated with serum diluted 1:100 in blocking buffer 
for 1 hour, washed 4 times in PBST and incubated with secondary goat-anti-human IgG-HRP (Horse Radish 
Peroxidase) (Labas OÜ, Tartu, Estonia) for one hour, washed 4 times, developed with SigmaFast OPD substrate 
(P9187-50, Sigma-Aldrich, Germany) for 5 minutes and read using Multiscan EX reader (Thermo Electron cor-
poration, USA). The optical density (OD) readings were averaged and normalized to both blank and human 
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IgG-coated wells using formula T = (ODexp-ODblank)/(ODIgG-ODblank) * 100. The experiments were not 
blinded, samples belonging to different groups were processed in parallel in identical manner.
Statistics. For ELISA tests results, Student’s t-test p values (two-tailed) were calculated between 
Endometriosis (E) and Endometriosis-free (N) groups using MS Excel. The rationale for pooling healthy and 
infertile subgroups against E was that if the test results were to be used for diagnostic purposes, they should be 
able to detect endometriosis against healthy as well as unhealthy background. To correct for multiple testing, 
FDRq values were calculated in R 3.2.2. Graphs were produced in R using Boxplot and Beeswarm modules. All 
data points represent the normalized average of two technical replicate readings.
Results
EXTL3 expression and colony formation in culture. EXTL3 expression. EXTL3 expression in endo-
metrial tissue has not been reported previously. Multiple RNA isoforms are produced from the EXTL3 gene in 
most tissues, several of which yield short cytoplasmic protein forms14. Therefore, PCR primers were designed 
targeting the exons required for full-length transmembrane protein expression. All 14 tested cDNAs from normal 
eutopic endometrial samples and samples from endometriosis lesions yielded a PCR product of expected 535 bp 
size (Fig. 1). One endometrioma from each patient was analyzed. All samples produced an easily detectable PCR 
band. We conclude that EXTL3 expression in endometrium is ubiquitous in patients and healthy individuals 
and not different in eutopic and endometriosis samples. Full length EXTL3 was cloned from eutopic endome-
trial cDNA using primers providing an improved translation initiation sequence and a mutated stop codon for 
fusion to enhanced GFP coding sequence. The constructs were verified by sequencing. To verify the construct’s 
functionality, the plasmid encoding the fusion gene was transfected into primary endometrial stromal cells and 
EGFP signal was observed in membrane-associated pattern as expected (Fig. 2A). The transfection efficiency was 
estimated to be <1%.
Colony formation in culture. The EXTL3-transfected endometrial stromal cells from endometriosis-free 
patients, and the same cells transfected with control EGFP vector were grown in DMEM-F12 with antibiotics, 
10% Fetal Calf Serum (FCS) (heat-inactivated), 10 µM estradiol, with 10% added human serum. The sera were 
not pooled. We tested 4 individual sera from endometriosis patients, and three sera from patients found negative 
for endometriosis by laparoscopy. EGFP signal was undetectable 4 days after transfection. The growth medium 
was not changed, and the cells were left unattended in the incubator for 6 weeks. The majority of the cells died, 
however, colonies of regeneration were observable. At 6 weeks, the number and size of the colonies was signif-
icantly different between the groups (Table 2 and Fig. 3). Significantly more colonies grew when both EXTL3 
and endometriosis serum were present (EXTL3 vs control - p = 0.002, Endometriosis vs control - p = 9.5 × 10−5, 
one-tailed t-test). These results indicate that the factors present in serum are specific to endometriosis and inter-
act with EXTL3.
Name Amino acid sequence
EXTL3-3 VTDFYRSW
PGRMC1 EDVVATGADPSDLESG
HPV16 E6 FYSKISEYRHYSYSLYGTTL
HPV155 L1 DQNPPPEKKDPYDEYTFWKV
HPV19 L1 DKNPPKEKVDPYKNLHFWNV
HSV1 gB PANAATRTSRGYEDQGPL
CMV UL11 VQNNDYVYWSFGGGGGNRLM
VZV D ASKYNSVGSKASLNGSGT
EchoV E11 VP1 AVPALTPGETGHTSQVTPS
HBoV VP1 QLHDHAYSELIKSGKNPYLY
HPyV7 VP1 SNQRTVQAGYGPAAVQEVT
Table 1. Peptides used in ELISA assays.
Figure 1. EXTL3 PCR products of 535 bp were produced from all cDNAs from eutopic endometrium (E) and 
endometriosis lesions (L). K04-K13 – healthy controls, E213-E47 – endometriosis patients, “−” – no template, 
gDNA – genomic DNA. Marker – Fermentas ZipRuler Express II.
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Figure 2. Fluorescently tagged protein expression in live transfected endometrial stromal cells (A) EXTL3-
EGFP (B) control EGFP.
Diagnosis Serum ID EGFP EXTL3-EGFPa
Endometriosis
E297 21 644
E319 26 682
E344 223 624
E355 44 462
Infertile, no 
endometriosis
E353 35
E356 18
E358 54
Table 2. Numbers of in vitro regenerating colonies depend on EXTL3 expression and endometriosis serum. 
aOn average 78 (EGFP) vs 603 (EXTL3-EGFP) colonies grew with endometriosis patients’ sera; both n = 4, 
t-test, one tailed p = 0.002; and 35 (infertile patient sera, n = 3) vs 603 (endometriosis patient sera, n = 4) for 
EXTL3-EGFP transfected cells, t-test, one tailed, p = 9.5 × 10−5.
Figure 3. Numbers of regenerating colonies in wells transfected with EXTL3 or control vector and grown with 
sera from endometriosis patients or endometriosis-free patients (mean ± SD). *p = 0.002, ***p = 9.5 × 10−5, 
one-tailed t-test.
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The colonies were EGFP negative and stained positive with W5C5 antibody (a marker for stromal stem cells) 
and CD9 antibody (a marker for endometrial epithelial cells). Surrounding cells around the colonies did not stain, 
serving as internal control (Fig. 4).
We wished to find out whether a truncation mutant of EXTL3 lacking the C-terminal glycosyltransferase 
domain had activity in this assay, in order to narrow down the functionally relevant domain. The EXTL3-ΔC 
construct coding for amino acids 1-660 of EXTL3 was prepared by PCR and expressed as fusion protein to EGFP 
in an identical manner to the full-length protein. In the following experiment, using eutopic endometrial stromal 
cells from a different donor (E305, who had infertility, but no endometriosis), the cells were transfected with 
wtEXTL3-EGFP, EXTL3-ΔC-EGFP, and EGFP plasmids and cultured with 5% human serum from an endome-
triosis patient. The colonies formed after two months, and were counted as follows: wtEXTL3 – 210; EXTL3-ΔC 
– 215; EGFP – 58; not transfected – 65; and NHS (no human serum) – 0. The results indicate that the serum fac-
tors interact with the N-terminal portion of EXTL3 and its glycosyltransferase domain is dispensable for colony 
formation activity.
Figure 4. Regenerating colonies and glandular structures in culture. Column 1 – Transfected with EGFP, 
cultured with sera from an endometriosis patient. Column 2 – Transfected with EXTL3-EGFP, cultured with 
sera from an endometriosis patient. Column 3 – Transfected with EXTL3-EGFP, cultured with serum from a 
patient without endometriosis. Row 1 – composite image of bright field, DAPI (blue), CD9 (green), and SUSD2-
W5C5 (red). The red signal is considerably weaker compared to the others. Row 2 – DAPI, row 3 – CD9, and 
row 4 – SUSD2 W5C5.
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Serum antibodies. EXTL3 antibodies. We had previously found EXTL3 antibodies in endometriosis 
serum. We therefore extended the search and designed synthetic peptide ELISA kits to measure the serum anti-
body titers to defined epitopes in target proteins. The study groups did not differ regarding age (average 33 years), 
height (average 166 cm), body weight (average 62 kg), and body mass index (average 22), t-test p > 0.1. We con-
sidered that the unstudied healthy control group might have occult endometriosis at the rate typical to general 
population (6–10%). The serological test results were above background levels in some of the control group mem-
bers. These were considered as false positive findings, due to lack of confirmatory evidence of endometriosis. 
However, the groups were still statistically different. We found increased antibody titers to EXTL3 peptide 3 
in endometriosis group (E) compared to endometriosis free (N) group (Fig. 5A). In comparison, antibodies to 
another endometrial cell surface antigen, progesterone receptor membrane component 1 (PGRMC1), were not 
significantly elevated in any of the study groups (Fig. 5B).
Antibodies to viruses. Next we measured antibody titers to various viruses we thought might be involved in endo-
metriosis. The study groups did not differ regarding age (average 32 years), height (average 167 cm), body weight 
(average 66 kg), and body mass index (average 24), t-test p > 0.1. We found significant differences between titers 
to viruses using HS for cell entry. Interestingly, in endometriosis patients the titers were lower, i.e. very seldom 
increased above background, compared to endometriosis-free group (N), comprising healthy and infertile sub-
jects. This applied to papillomavirus capsid antigens (L1) as well as early intracellular antigen E6. The differences 
between healthy and endometriosis-free infertile subgroups were non-significant. The titers for HPV16 E6 antigen, 
HPV155 L1 and HPV19 L1 antigen differed significantly between the E and N groups (Fig. 6A–C). We also found 
significantly fewer elevated titers for HSV-1 and CMV (cytomegalovirus, HHV5), but not for VZV (varicella zoster 
virus) in the endometriosis group (Fig. 6D–F). The antibody titers for human polyomavirus 7 (HPyV7) are signif-
icantly less frequently increased in endometriosis group (Fig. 6G). The antibody titers for other viruses, which do 
not use heparan sulfate receptors, but are known to use sialic acid (SA) did not differ between the study groups. 
Antibodies for a human echovirus E11 peptide (89% similar to E31 and E19) were equally present in all groups 
(Fig. 6H), also, the antibodies for human bocavirus VP1 peptide were equally distributed (Fig. 6I).
Figure 5. (A) Serum antibody titers to EXTL3, as measured by ELISA, are increased in endometriosis. 
* - Student’s two-tailed t-test p = 0.042, E: MEAN = 24.1; SEM = 5.42; n = 15 vs. N: MEAN = 13.21; 
SEM = 2.53; n = 29. (B) titers to PGRMC1 do not differ between groups. Student’s two-tailed t-test p = 0.37, 
E: MEAN = 2.39; SEM = 0.80; n = 9 vs. N: MEAN = 3.61; SEM = 0.84; n = 16. E – endometriosis, N – 
Endometriosis-free.
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Discussion
Unknown serum factors from endometriosis patients have been found to induce umbilical cord mesenchy-
mal stem cell differentiation into endometrial cells5. Our data confirm and extend these findings, identifying a 
target molecule for the serum factors as EXTL3. We found increased anti-EXTL3 antibodies in endometriosis 
patients’ sera. EXTL3 is a membrane signaling molecule and has been documented to signal via PI3K pathway13. 
Antibody-mediated aggregation may contribute to such signaling mode, while at the same time inhibiting gly-
cosyltransferase function and altering BMP and FGF pathways. We cannot rule out the presence of other factors 
in addition to EXTL3 antibodies, or other possible targets. We have not measured the levels of REG3A, a ligand 
of EXTL3.
As EXT proteins, including EXTL3 perform one of the key steps in HS synthesis, we measured antibody 
titers to viruses, which use HS as a receptor for cell entry, and found rarely increased titers for these viruses in 
the endometriosis group, whereas titers to viruses using other receptors were equally distributed between study 
groups. This applied to viruses from different families. Viral binding to and entry into cells requires attachment 
to HS, while the binding is blocked by soluble HS12,15. Our finding that antibody titers to HS-binding viruses 
are seldom increased in endometriosis patients may indicate that replication of HS-requiring viruses is ham-
pered, possibly by reduction of synthesis of HS, reduction of specific sulfation, or by soluble HS. Concurrently, 
we cannot exclude the possibility that the difference in antiviral antibody titres stems from reduced exposure. 
Endometriosis-associated dyspareunia may reduce the number of sexual contacts and, consequently, sexually 
transmitted viruses, such as papillomavirus and herpesvirus. Associations between endometriosis, sexual behav-
iour and viruses should be studied in more detail in the future. In our results, the t-test p-values ranked neatly 
according to the published HS specificity of the viruses (Table 3).
HPV16 binds HS16. The exact receptor specificity has not been elucidated for HPV155 and HPV19, but their 
tropism is similar to HPV16, i.e. skin and vagina17.
Among herpesviruses, the use of GAG for cell entry is variable. HSV-1 attaches by glycoprotein D (gD) to 
3-O-sulfated HS on nectin and herpesvirus entry mediator (HVEM). gD is one of the very few proteins known 
to bind this HS modification specifically. Glycoprotein B (gB) of human herpesvirus 5 (CMV) also binds HS 
Figure 6. Serum antibody titers to viral antigens, as measured by ELISA, depend on the virus entry receptor 
and whether the patient has endometriosis. In endometriosis group (E) the titers are rarely increased against 
viruses binding to heparan sulfate (HPV16, HSV1, CMV), whereas in Endometriosis-free (N) group the titers 
are higher (* - q < 0.05). Titers against viruses binding sialic acid receptors (Echovirus and Bocavirus) are 
not significantly different between the groups. (A) HPV16-E6, p = 0.0064, FDRq = 0.0346; (B) HPV155-L1, 
p = 0.0012, FDRq = 0.0270; (C) HPV19-L1, p = 0.0096, FDRq = 0.0346; (D) HSV1, p = 0.01, FDRq = 0.0346; 
(E) CMV (HHV5), p = 0.018, FDRq = 0.0436; (F) VZV, p = 0.08, FDRq = 0.0685; (G) human polyomavirus 7 
(HPyV7), p = 0.013, FDRq = 0.0388; (H) Echovirus VP1, p = 0.64, FDRq = 0.3697; and (I) Human bocavirus 
(HBoV) VP1, p = 0.94, FDRq = 0.4867 (Student’s two-tailed t-test, E (n = 9) vs. N (n = 16)).
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but also other receptors. Both HS-deficient Chinese hamster ovary cells and fibroblast cells with enzymatically 
removed HS had 40% reductions in gB binding, whereas removal of chondroitin sulfate had no effect, however, 
a significant proportion of gB is able to associate with the cell surface in the absence of HS via an undefined non-
heparin component18. HHV3, varicella-zoster virus (VZV) on the other hand has been found to bind insulin-like 
growth factor 2 receptor (IGF2R, also known as cation-independent mannose-6-phosphate receptor, CI-MPR)19 
or myelin-associated glycoprotein instead20, neither of which have been reported to carry sulfated GAGs.
Polyomaviruses are very common viruses on human skin, seropositivity has been reported between 35–90%21. 
The receptor for HPyV7 has not been identified, but the receptor binding site at the capsid of HPyV7 is signifi-
cantly different from other polyomaviruses, whose receptor is sialic acid and HPyV7 has been shown not to bind 
SA22. It is therefore possible that HPyV7 uses HS as its receptor. In contrast, titres to viruses known to bind SA 
for cell entry were equally distributed. Echoviruses bind to SA residues on CD5523. Human bocavirus (HBoV) is 
a ssDNA virus, also binding to SA24,25.
We therefore propose that the data we have collected is indicative of HS metabolism perturbations being 
associated with endometriosis, perhaps being a part of its pathogenesis. HS regulate many aspects of cell biol-
ogy. In multiple exostoses syndrome, caused by mutated EXT, the osteochondroma development is caused by 
excessive bone morphogenetic protein (BMP) signaling that would normally be regulated by HS26. Therefore it 
is possible that the serum antibodies inhibiting the EXTL3 activity or interactions reduce HS synthesis resulting 
in disinhibition of BMP signaling. Among the BMP family members, BMP7 induces mesenchymal-to-epithelial 
transition in the metanephrogenic blastema and leads to the development of nephron tubules and glomeruli27. 
Conversely, its attenuated expression leads to epithelial-to-mesenchymal transition (EMT) and fibrosis28. BMP7 
has been shown to signal via BMPR1A29. BMPR1A is highly expressed in uterus30. BMP7 is regulated by HS. In 
osteoblastic cells, cell surface-attached HS is required for BMP7 signaling-induced SMAD phosphorylation, and 
can be blocked by heparin or heparitinase treatment31. The biological activity of fibroblast growth factor (FGF) 
family proteins is also regulated by interactions with HS, which facilitates receptor-ligand complex formation32. 
FGF family proteins are involved in mesenchymal stem cell differentiation33–35. Interestingly, this interaction is 
facilitated also by soluble, partially degraded HS. We hypothesize that the change in balance of cell-attached vs. 
soluble HS may change the balance of BMP and FGF signaling and contribute to endometriosis pathogenesis. 
Large amounts of soluble HS are released during ovulation in follicular fluid, where it functions as an anticoagu-
lant36. This HS in combination with EXTL3 antibodies may induce differentiation of resident mesothelial cells37 
or endometrial stromal cells present due to retrograde menstruation. Somatic stem cell origin of endometriosis 
has been proposed, however, cell-intrinsic factors, such as genetic and epigenetic differences have been focused 
on before38. As EXTL3 is a signaling cell surface receptor for REG3A, as well as a glycosyltransferase, it is capable 
of regulating the balance of HS-bearing receptor signaling vs. REG3A signaling. Antibodies targeting EXTL3 may 
block HS synthesis, or induce signaling through the PI3K, or both. The fact that colony formation required the 
presence of both the overexpressed EXTL3 and endometriosis serum, indicates a positive interaction. However, it 
is also possible that EXTL3 interacts with soluble HS, or that the antibodies target HS.
Endometriosis is strongly associated with infertility4. It is therefore puzzling why the factors predisposing 
to such an unfavorable condition have been preserved in evolution. The current finding is that endometriosis 
patients appear to be significantly less frequently infected with DNA viruses, particularly the oncogenic HPV16, 
whereas the control group seropositivity is comparable to published average healthy population levels17.
In conclusion, we have detected EXTL3 expression in endometrial tissue as well as endometriosis lesions. 
We have found that serum from endometriosis patients contains a factor or factors, which interact with EXTL3 
resulting in strongly increased colony formation in regenerating cell culture. We have found that antibody titers 
to viruses, which use HS as a receptor for cell entry, are rarely increased in the endometriosis group, whereas titers 
to viruses using SA show no difference between groups. Since EXTL3 is involved in HS synthesis, we measured 
antibody titers to EXTL3 and found increased titers in endometriosis group. However, the etiological factors 
inducing EXTL3 autoantibodies and HS metabolism perturbation still remain to be identified.
Data Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
Virus Receptor t-test p FDR q
HPV155 ND 0.0012 0.0270
HPV16 HS 0.0064 0.0346
HPV19 ND 0.0096 0.0346
HSV1 HS 0.01 0.0346
HPyV7 Not SA 0.013 0.0388
CMV HS and FcGR 0.018 0.0436
VZV IGF2R, MAG 0.08 0.0685
Echovirus SA 0.64 0.3697
HBoV SA 0.94 0.4867
Table 3. The statistical significance values of the titer differences (t-test, two-tailed) follow the reported receptor 
usage of the viruses. ND – not determined specifically, FcGR – Immunoglobulin G receptor.
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